MARSIGLIANTE, Santo
 Distribuzione geografica
Continente #
EU - Europa 14.243
NA - Nord America 12.356
AS - Asia 9.601
SA - Sud America 1.596
Continente sconosciuto - Info sul continente non disponibili 387
AF - Africa 237
OC - Oceania 11
AN - Antartide 1
Totale 38.432
Nazione #
US - Stati Uniti d'America 11.721
IT - Italia 4.851
SG - Singapore 4.345
IE - Irlanda 3.317
RU - Federazione Russa 2.593
CN - Cina 1.746
HK - Hong Kong 1.388
BR - Brasile 1.300
VN - Vietnam 852
SE - Svezia 845
UA - Ucraina 746
DE - Germania 513
IN - India 420
FI - Finlandia 340
FR - Francia 327
CA - Canada 310
GB - Regno Unito 292
KR - Corea 203
BD - Bangladesh 136
AR - Argentina 117
MX - Messico 113
JP - Giappone 101
ZA - Sudafrica 83
PL - Polonia 74
IQ - Iraq 69
EC - Ecuador 55
SN - Senegal 52
BE - Belgio 51
ES - Italia 50
PK - Pakistan 50
TR - Turchia 50
NL - Olanda 48
ID - Indonesia 42
CZ - Repubblica Ceca 38
LT - Lituania 35
SV - El Salvador 31
CR - Costa Rica 29
IR - Iran 29
GT - Guatemala 25
VE - Venezuela 25
CO - Colombia 23
AT - Austria 22
GP - Guadalupe 22
JM - Giamaica 22
PY - Paraguay 21
UZ - Uzbekistan 21
AE - Emirati Arabi Uniti 20
CL - Cile 20
CW - ???statistics.table.value.countryCode.CW??? 18
KE - Kenya 17
IL - Israele 16
PE - Perù 16
TT - Trinidad e Tobago 16
MA - Marocco 15
TN - Tunisia 15
HN - Honduras 14
MY - Malesia 14
SA - Arabia Saudita 14
NP - Nepal 13
PR - Porto Rico 13
NI - Nicaragua 12
BG - Bulgaria 11
CH - Svizzera 11
EG - Egitto 11
RO - Romania 11
BO - Bolivia 10
DZ - Algeria 10
ET - Etiopia 10
SC - Seychelles 9
AL - Albania 8
EE - Estonia 8
HU - Ungheria 8
JO - Giordania 8
UY - Uruguay 8
AU - Australia 7
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
PS - Palestinian Territory 6
RS - Serbia 6
LB - Libano 5
PT - Portogallo 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BH - Bahrain 4
EU - Europa 4
GR - Grecia 4
KW - Kuwait 4
MD - Moldavia 4
PH - Filippine 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
AM - Armenia 3
BW - Botswana 3
BZ - Belize 3
CI - Costa d'Avorio 3
DK - Danimarca 3
GD - Grenada 3
Totale 38.013
Città #
Lecce 3.663
Dublin 3.313
Singapore 1.589
Ashburn 1.318
Hong Kong 1.282
San Jose 1.259
Council Bluffs 1.018
Moscow 794
Chandler 711
Dallas 583
Beijing 431
Jacksonville 422
New York 390
Ho Chi Minh City 304
Los Angeles 249
Santa Clara 241
Wayanad 234
Princeton 230
Milan 218
Lauterbourg 209
Hanoi 208
Seoul 198
Munich 177
São Paulo 146
Des Moines 136
Frankfurt am Main 119
Tokyo 96
Orem 95
Phoenix 93
Montreal 87
Brooklyn 83
Wilmington 82
Helsinki 81
Ann Arbor 80
Chicago 80
West Jordan 78
Central District 77
Atlanta 75
Seattle 71
Rome 70
Bari 69
Ogden 69
Denver 65
London 64
Chennai 62
Warsaw 59
Dakar 52
Mexico City 52
Toronto 51
Boston 49
Lequile 49
Boardman 47
Brussels 47
Miano 47
Stockholm 46
Houston 45
Poplar 45
Rio de Janeiro 45
Johannesburg 44
North Bergen 44
Da Nang 42
Detroit 41
Turku 41
Naples 37
Columbus 36
Haiphong 36
San Francisco 36
Seelze 34
The Dalles 32
Manchester 31
Kent 30
Miami 29
Copertino 28
Guangzhou 28
Jinan 27
San Pietro Vernotico 27
San Salvador 27
Amsterdam 26
Bremen 26
Falls Church 26
Baghdad 25
Bakersfield 25
Brasília 25
Mumbai 25
Ankara 24
Augusta 24
Falkenstein 24
Brno 23
Nuremberg 23
San José 23
San Mateo 23
Tianjin 22
Belo Horizonte 21
Biên Hòa 21
Bologna 21
Querétaro 20
Shanghai 20
Tashkent 20
Guarulhos 19
Lappeenranta 19
Totale 22.728
Nome #
Exchequer motor game enhances geometric thinking and mood in first grade children 269
Evaluation of the Antitumor Effects of Platinum-Based [Pt(η1-C2H4-OR)(DMSO)(phen)]+ (R = Me, Et) Cationic Organometallic Complexes on Chemoresistant Pancreatic Cancer Cell Lines 268
A monoclonal antibody to mammalian Angiotensin II AT1 receptor recognises one of the Angiotensin II receptor isoforms expressed by the eels. 265
INJURY PREVENTION IN YOUNG SOCCER PLAYERS: RESULTS OF A PILOT STUDY 263
[Pt(O,O'-acac)(γ-acac)(DMS)] induces autophagy and apoptosis in Skov-3 ovarian carcinoma cells 258
[Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway 257
ADP sensitizes ZL55 cells to the activity of cisplatin 255
A new class of Pt(II) complexes with acetylacetonate as carrier ligand: reactivity and biological behaviour 253
Inhibition of ZL55 cell proliferation by ADP via PKC-dependent signalling pathway 252
[Pt(O,O′-acac)(γ-acac)(DMS)] inhibits malignant pleural mesothelioma cells in vitro and in vivo 249
A new platinum(II) complex with high cytotoxicity in human endometrial cancer HeLa cells. 248
Referees' physical performance over a soccer season 245
[Pt(O,O'-acac)(γ-acac)(DMS)] Induces Autophagy in Caki-1 Renal Cancer Cells 243
A new platinum(II) complex with high cytotoxicity in human breast cancer MCF-7 cells. 241
A new platinum (II) complex exerts higher cytotoxicity in tumoral than in normal human breast cells in primary culture. 238
3,5-Diiodo-l-thyronine induces SREBP-1 proteolytic cleavage block and apoptosis in human hepatoma (Hepg2) cells. 237
Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma 237
A new platinum(II) complex with high cytotoxicity in human breast cancer MCF-7 cells 236
3,5,3'TRIIODO-L-THYRONINE INDUCES SREBP-1 EXPRESSION BY NON-GENOMIC ACTIONS IN HUMAN HEP G2 CELLS 236
[Pt(O,O'-acac)(gamma-acac)(DMS)] alters the expression of genes for cell cycle regulation and invasive function 234
[Pt(O,O’-acac)(γ-acac)(DMS)] affects the intracellular Ca2+ homeostasis in MCF-7 breast cancer cells 233
ADP sensitizes ZL55 cells to the activity of anticancer cisplatin 233
A new platinum(II) complex with high cytotoxicity in normal and tumoural thyroid cell lines 232
[Pt(O,O’-acac)(γ-acac)(DMS)] exerts high and fast cytotoxicity in breast cancer cells in primary culture 230
Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells 230
Ionic transports in teleost osmoregulation 227
Antitumor and Antiangiogenic Activities of [Pt(O,O' acac)(γ-acac)(DMS)] in human renal cell carcinoma 225
[Pt(O,O’-acac)(γ-acac)(DMS)]: in vivo Studies of a Promising Anticancer Drug in Cancer Therapy 224
In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma 222
[Pt(O,O’-acac)(γ-acac)(DMS)]: a comparative study with cisplatin in vivo. 222
[Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway. 221
1H-NMR metabolomic study of SKOV-3 cells, response to the [Pt(O,O′-acac)(γ-acac)(DMS)] treatment 221
Antitumor and antimigration effects of a new Pt compound on neuroblastoma cells 220
PKC-δ/PKC-α activity balance regulates the lethal effects of cisplatin 219
An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects 217
4 S oestrogen receptor isoforms and their distribution in breast cancer samples 213
Activation of P2Y2 purinoceptor inhibits the activity of the Na+/K+ATPase in HeLa cells 213
Cytotoxicity of new organometallic Pt(II)-complexes containing 1,10-phenantroline 212
A filtration-based real-time PCR method for the quantitative detection of viable Salmonella enterica and Listeria monocytogenes in food samples. 211
Cytotoxic effects of [ Pt( O,O' – acac)(γ-acac)(DMS)] and cisplatin in Caki-1 renal cancer cells 211
B-DIKETONATE PLATINUM(II) COMPLEXES SHOWING HIGHER CYTOTOXIC ACTIVITY THAN CISPLATIN ON CANCER CELLS. 209
Angiotensin II receptor subtypes in eel (Anguilla anguilla) 208
Antitumor activity of [Pt(O,O’-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer 208
Response of cisplatin resistant SkOV-3 cells to [PT(O,O'-Acac)(γ-Acac)(DMS)] Treatment revealed by a metabolomic 1H-NMR study 208
The effects of exercise training on lipid metabolism and coronary heart disease 208
Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma cells 208
[Pt(O,O’-acac)(γ-acac)(DMS)] inhibits adhesion and migration of breast cancer cells 207
Sintesi e caratterizzazione di nuovi analoghi del cisplatino conformazionalmente stabilizzati. 205
The effects of training on hormonal concentrations in young soccer players 205
Computerised counting of the tumour infiltrating lymphocytes in ninety breast cancer specimens. 204
Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture. 204
Cisplatin-analogous β-diketonate Pt(II) organometallic species: reactivity and cytotoxicity 200
Activation of P2Y2 receptor induces C-Fos protein through a pathway Involving Mitogen-Activated Protein Kinase and phosphoinositide 3-kinases in HeLa cells. 199
[Pt(O,O′-acac)(γ-acac)(DMS)] inhibits migration of tumor human breast cells in primary cultures 198
A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells 197
Antitumor Effects Induced by the Promising Drug [Pt(O,O′-acac)(γ-acac)(DMS)] in Cisplatin Resistant Epithelial Ovarian Carcinoma Cell Line (SKOV-3): a 1H NMR Metabolomic Study 197
Angiotensin II stimulates the Na+/H+ exchanger in human umbilical vein endothelial cells via AT1 receptor 196
Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells 193
Differential functions of PKC-delta and PKC-zeta in cisplatin response of normal and transformed thyroid cells. 193
[Pt(O,O’-acac)(γ-acac)(DMS)] induces apoptosis in human breast cancer cells in primary culture 192
Is mitochondrial DNA profiling predictive for athletic performance? 191
An L-proline-dependent proton flux is located at the apical membrane level of the eel enterocytes. 190
Cisplatin activates the PKC/ERK1/2 intracellular transduction pathways in rat thyroid PC Cl3 cells 188
Angiotensin II stimulation of the basolateral located Na/H antiporter in eel (Anguilla anguilla) enterocytes 186
Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment 186
Cytotoxicity of [Pt(O,O’-acac)(γ-acac)(DMS)] in normal and cancerous human breast cells in primary culture 183
Dopamine and antioxidant grape seed extract loaded chitosan nanoparticles: A preliminary in vitro characterization. 181
Bradykinin stimulates prostaglandin E2 release in human skeletal muscular fibroblasts 181
Immunolocalization of the AT-1R Ang II Receptor in Human Kidney Cancer 180
NMR-based metabolomic analyses of cisplatin resistant SKOV-3 cell line response to [Pt (O,O′-acac)(γ-acac)(DMS)], Ptac2S, treatment: comparison to cisplatin 179
Characterization of Na+/H+ antiporter activity in PC-Cl3 thyroid cells 178
Synthesis and comparative evaluation of the cytotoxic activity of cationic organometallic complexes of the type [Pt(η1-CH2-CH2-OR)(DMSO)(phen)]+ (R = Me, Et, Pr, Bu) 176
The Angiosuppressive Effects of [Pt(O,O′-acac)(γ-acac)(DMS)] 176
Different regulation of matrix metalloproteinase-2 in cisplatin response of normal and transformed thyroid cells 175
New mononuclear and homodinuclear Pt(II) complexes with heterocyclic nitrogen chelates: Synthesis, characterization, intercalating ability and in vitro cytotoxic activity evaluation 174
Protein kinase C-delta mediates cisplatin-induced apoptosis of ZL55 mesothelioma cells 174
Adenosine diphosphate regulates MMP2 and MMP9 activity in malignant mesothelioma cells 174
Multiple isoforms of the oestrogen receptor in endometrial cancer 173
Immunolocalisation of angiotensin II receptors in icefish (Chionodraco hamatus) tissues. 173
Multiple pathways for cationic amino acid transport in rat thyroid epithelial cell line PC Cl3 172
Synthesis and characterization of new water-soluble organometallic complexes of the type [PtL(h1-C2H4OMe)(N^N)] (L = NH3, DMSO; N^N = dinitrogen ligand) with potential antitumor activity 172
NEW B-DIKETONATE PT(II) ORGANOMETALLIC SPECIES EXHIBITING HIGHER CYTOTOXIC ACTIVITY ON CANCER CELLS THAN CISPLATIN. 171
Cytotoxic Activity of New β-Diketonate Platinum(II) Complexes on Cancer Cells 171
A new platinum(II) compound anticancer drug candidate with selective cytotoxicity for breast cancer cells 171
AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma 170
PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells 170
A novel monoclonal antibody to a plasmamembrane-located breast cancer antigen Interferes with the proliferation rate of cancerous cells in vitro 169
CCL20 promotes migration and invasiveness of human cancerous breast epithelial cells in primary culture 169
Mitochondria-mediated apoptosis by a new Pt(II) compound, [Pt(O,O’-acac)(g-acac) (DMS)], in human breast cancer cells 168
Angiotensin II AT1 Receptor Stimulates Na+/K+ATPase Activity Through a Pathway Involving PKC-z in Rat Thyroid Cells. 168
Biological interest of four -coordinate complexes of platinum with Bathophenanthroline and Bathocuproine sulfonates 167
Purinergic receptors in a pleural mesotelioma cell line. 166
Effect of tumour size on the association between pS2 and cathepsin D in primary breast cancer 165
Involvement of Protein Kinase Cdelta and -epsilon in cisplatin-induced apoptosis in thyroid cells. 164
Increase of [Ca2+]i via activation of ATP receptors in PC-Cl3 rat thyroid cell line 163
Angiotensin II modulates the activity of Na+/K+ATPase in cultured rat astrocytes via the AT1 receptor and protein kinase C-delta activation 162
Synthesis, characterization and cytotoxic activity of novel Pt(II) complexes with acetylacetonate and amines 161
Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. 160
Novel Pt (II) Complexes With Anticancer Activity Against Pancreatic Ductal Adenocarcinoma Cells 159
Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples 159
Totale 20.374
Categoria #
all - tutte 173.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.453


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022908 0 0 0 96 153 16 26 73 23 63 151 307
2022/20235.720 259 410 207 208 228 351 33 273 3.517 13 145 76
2023/20241.801 157 102 127 98 134 174 22 61 262 374 205 85
2024/20256.131 104 33 133 101 386 740 187 294 2.042 614 563 934
2025/202614.229 1.303 1.750 1.306 1.928 1.429 674 1.659 647 1.936 913 470 214
2026/20274.089 359 930 663 2.137 0 0 0 0 0 0 0 0
Totale 38.432